PMID- 29400123 OWN - NLM STAT- MEDLINE DCOM- 20180823 LR - 20180823 IS - 1477-0962 (Electronic) IS - 0961-2033 (Linking) VI - 27 IP - 3 DP - 2018 Mar TI - Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels. PG - 380-388 LID - 10.1177/0961203317723716 [doi] AB - Background This study was performed to assess adhesion molecules in systemic lupus erythematosus (SLE). Methods This case-control study examined 126 SLE patients and 48 healthy individuals. Blood levels of six adhesion molecules, cortisol, nuclear autoantibody (ANA) and anti-double stranded DNA (anti-dsDNA) titers were measured, while disease activity was assessed using the SLE Disease Activity Index (SLEDAI) score. Results Platelet endothelial cell adhesion molecule 1 (PECAM-1), vascular cell adhesion molecule 1 (VCAM-1), E-selectin, P-selectin, and plasminogen activator inhibitor type-1 (PAI-1) were significantly higher in SLE patients than in controls. Binary logistic regression analysis showed that PECAM-1 and PAI-1 predicted SLE with a sensitivity of 86.5% and a specificity of 81.3%. ANA titers were significantly and positively associated with PECAM-1, VCAM-1, E-selectin, and PAI-1, whereas there were no associations between anti-dsDNA titers and adhesion molecules. Cortisol was negatively associated with PCAM-1 and ICAM-1. There were significant associations between metabolic syndrome (MetS) and E-selectin and PAI-1. 14.8% of the variance in the SLEDAI score was explained by the regression on PECAM-1 and MetS. Conclusions Our data show that adhesion molecules, especially PECAM-1, are significantly associated with SLE and disease activity, suggesting that they play a role in SLE pathophysiology. While MetS, ANA titers and cortisol levels modulate adhesion molecule levels, these associations do not explain the increased levels of adhesion molecules in SLE. Increased levels of adhesion molecules are new drug targets in SLE. FAU - da Rosa Franchi Santos, L F AU - da Rosa Franchi Santos LF AD - 1 Graduate Program in Pathology, Clinical Analysis and Toxicology, University of Londrina, Brazil. FAU - Stadtlober, N P AU - Stadtlober NP AD - 1 Graduate Program in Pathology, Clinical Analysis and Toxicology, University of Londrina, Brazil. FAU - Costa Dall'Aqua, L G AU - Costa Dall'Aqua LG AD - 1 Graduate Program in Pathology, Clinical Analysis and Toxicology, University of Londrina, Brazil. FAU - Scavuzzi, B M AU - Scavuzzi BM AD - 2 Graduate Program in Health Sciences, University of Londrina, Brazil. FAU - Guimaraes, P M AU - Guimaraes PM AD - 2 Graduate Program in Health Sciences, University of Londrina, Brazil. FAU - Flauzino, T AU - Flauzino T AD - 2 Graduate Program in Health Sciences, University of Londrina, Brazil. FAU - Batisti Lozovoy, M A AU - Batisti Lozovoy MA AD - 3 Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Brazil. FAU - Mayumi Iriyoda, T V AU - Mayumi Iriyoda TV AD - 4 Department of Rheumatology, University of Londrina, Brazil. FAU - Vissoci Reiche, E M AU - Vissoci Reiche EM AD - 3 Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Brazil. FAU - Dichi, I AU - Dichi I AD - 5 Department of Internal Medicine, University of Londrina, Brazil. FAU - Maes, M AU - Maes M AD - 6 IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia. FAU - Colado Simao, A AU - Colado Simao A AD - 3 Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Brazil. LA - eng PT - Journal Article DEP - 20180205 PL - England TA - Lupus JT - Lupus JID - 9204265 RN - 0 (Antibodies, Antinuclear) RN - 0 (Biomarkers) RN - 0 (Cell Adhesion Molecules) RN - WI4X0X7BPJ (Hydrocortisone) SB - IM MH - Adult MH - Antibodies, Antinuclear/*blood MH - *Autoimmunity MH - Biomarkers/blood MH - Body Mass Index MH - Brazil MH - Case-Control Studies MH - Cell Adhesion Molecules/*blood MH - Female MH - Humans MH - Hydrocortisone/*blood MH - Logistic Models MH - Lupus Erythematosus, Systemic/*blood/physiopathology MH - Male MH - Metabolic Syndrome/*complications MH - Middle Aged MH - Multivariate Analysis MH - Severity of Illness Index OTO - NOTNLM OT - ANA OT - Systemic lupus erythematosus OT - adhesion molecules OT - body mass index OT - cortisol OT - metabolic syndrome EDAT- 2018/02/06 06:00 MHDA- 2018/08/24 06:00 CRDT- 2018/02/06 06:00 PHST- 2018/02/06 06:00 [pubmed] PHST- 2018/08/24 06:00 [medline] PHST- 2018/02/06 06:00 [entrez] AID - 10.1177/0961203317723716 [doi] PST - ppublish SO - Lupus. 2018 Mar;27(3):380-388. doi: 10.1177/0961203317723716. Epub 2018 Feb 5.